Green Diabetes Summit 2021

Nguyen, Kevin Tri; Xu, Nicole Y; Zhang, Jennifer Y; Shang, Trisha; DuBord, Ashley Y; Heinemann, Lutz; Krisiunas, Edward; Stumpe, Tobias; Seid, Donna; Klonoff, David C.

doi:10.1177/19322968211049800

Cited by 9 publications

(9 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…To the best of our knowledge, there was no data available about home disposal practices of medical sharps in the Portuguese diabetic population, as in many other countries 20. We found clear evidence of inadequate disposal of medical sharps among these patients, findings that are corroborated by studies in the same scope conducted in other countries, which reported household bin disposal of medical sharps ranging from 33% to 92%,3 7 8 10 13 15 17 18 21–28 a common problem worldwide 9. Our results show that over two-thirds of diabetic patients discard sharps directly into common household bins.…”

Section: Discussionsupporting

confidence: 76%

Medical sharps in Portugal: a cross-sectional survey of disposal practices among the diabetic population

Corte-Real¹,

Duarte²,

Teixeira³

et al. 2022

BMJ Open

View full text Add to dashboard Cite

ObjectiveWe aim to determine the disposal site for biohazardous materials resulting from diabetes surveillance and therapy.DesignCross-sectional study.SettingFive Portuguese primary care facilities.ParticipantsWe randomly sampled diabetic patients representative of five primary care facilities. Inclusion criteria consisted in patients≥18 years old with an active diagnosis of diabetes mellitus (DM). Patients unable to provide written informed consent were excluded.Outcome measureSociodemographic variables, diabetes duration, type of treatment, medical sharps disposal practices and whether adequate disposal information were provided.ResultsA total of 1436 diabetics were included. Overall, 53.8% of diabetics conducted regular capillary glicemia measurements, although 45.3% of them had no medical indication. Statistically significant predictors of adequate disposal were not having an active professional status (p=0.011) and having a DM duration between 5 and 10 years (p=0.014). Only being professionally inactive remained an independent predictor after multivariate logistic regression. Less than a fifth of patients on injectable therapy report having been advised by healthcare staff regarding sharps disposal. Over a fifth of the latter report having received wrong advice. The majority of diabetics dispose of biohazardous materials in unsorted household waste (68.1% of needles/devices with needles and 71.6% of lancets). Other incorrect disposal sites identified were recycling bins, toilet and home accumulation. Only 19.1% of the needles/devices with needles and 13.1% of the lancets were disposed of at healthcare facilities.ConclusionsMost diabetics have unsafe disposal practices for their biohazardous materials, mostly in unsorted household waste. We identified that being unemployed independently predicts adequate disposal of medical sharps and found evidence of low patient literacy on the topic, as well as poor patient education. Therefore, educating and raising awareness among healthcare professionals is crucial to address this public health issue.

show abstract

Section: Discussionsupporting

confidence: 76%

Medical sharps in Portugal: a cross-sectional survey of disposal practices among the diabetic population

Corte-Real¹,

Duarte²,

Teixeira³

et al. 2022

BMJ Open

View full text Add to dashboard Cite

show abstract

“…4 As part of this commitment, in July 2021, the DTS convened the Green Diabetes Summit. The virtual event brought together 23 representatives from the USA and Europe, 5 including Professor Lutz Heinemann, CEO, Science Consulting in Diabetes, Kaarst, Germany.…”

Section: Green Diabetes Summitmentioning

confidence: 99%

“…3 Now 50 years after the Woods Hole report, a collaboration including medical specialists, environmental health experts and manufacturers seems set to reduce the environmental footprint left by plastics used in diabetes care. 4,5 After all, disposable diabetes devices -such as needles, syringes and pens, lancets, blood glucose monitoring strips and monitors, continuous glucose sensors, insulin bottles, infusion tubing, disposable pumps and batteries -create enormous amounts of plastic and other waste. 4 Yet the diabetes care product may represent only 10% of the total weight and volume.…”

mentioning

confidence: 99%

The greening of diabetes

Greener¹

2023

Practical Diabetes

View full text Add to dashboard Cite

show abstract

“…29,30 On July 21, 2021, Diabetes Technology Society convened the Green Diabetes Summit (GDS), a milestone event to discuss for the first time in an international forum how diabetes affects the environment. 31 The GDS assembled healthcare professionals, representatives from patient organizations, waste management experts, government agencies, and device manufacturers from the U.S. and six European countries. The purposes of the GDS were (1) to provide background on the complexity of diabetes device sustainability and waste management from a variety of perspectives, and (2) to determine the feasibility and role of a coalition of stakeholders to address issues in sustainability and waste management that no single stakeholder can resolve on their own.…”

Section: The Green Initiative To Reduce Plastic and Insulin Wastementioning

confidence: 99%

Improving the Patient Experience With Longer Wear Infusion Sets Symposium Report

Nguyen

Buckingham

et al. 2022

J Diabetes Sci Technol

Self Cite

View full text Add to dashboard Cite

Continuous subcutaneous insulin infusion (CSII) therapy is becoming increasingly popular. CSII provides convenient insulin delivery, precise dosing, easy adjustments for physical activity, stress, or illness, and integration with continuous glucose monitors in hybrid or other closed-loop systems. However, even as insulin pump hardware and software have advanced, technology for insulin infusion sets (IISs) has stayed relatively stagnant over time and is often referred to as the “Achilles heel” of CSII. To discuss barriers to insulin pump therapy and present information about advancements in, and results from clinical trials of extended wear IISs, Diabetes Technology Society virtually hosted the “Improving the Patient Experience with Longer Wear Infusion Sets Symposium” on December 1, 2021. The symposium featured experts in the field of IISs, including representatives from Steno Diabetes Center Copenhagen, University of California San Francisco, Stanford University, Medtronic Diabetes, and Science Consulting in Diabetes. The webinar’s seven speakers covered (1) advancements in insulin pump therapy, (2) efficacy of longer wear infusion sets, and (3) innovations to reduce plastics and insulin waste.

show abstract

Green Diabetes Summit 2021

Cited by 9 publications

References 13 publications

Medical sharps in Portugal: a cross-sectional survey of disposal practices among the diabetic population

Medical sharps in Portugal: a cross-sectional survey of disposal practices among the diabetic population

The greening of diabetes

Improving the Patient Experience With Longer Wear Infusion Sets Symposium Report

Contact Info

Product

Resources

About